Back to search

University of Crete (UOC)

Μελέτη του ρόλου της σωματοστατίνης και κορτιστατίνης στον αμφιβληστροειδή και στην ισχαιμική αμφιβληστροειδοπάθεια

Abstract

dc:description

The main aim of this thesis was to investigate the neuroprotective role of somatostatin (SRIF) and its analogues against retinal ischemia. The following specific objectives were posed: to study the functional role of sst1 and sst2 somatostatin receptors, to establish a retinal model of ischemia, to ascertain the neuroprotective actions of SRIF and its analogues in this model, and to elucidate the mechanism involved in the neuroprotection. The results of this thesis suggest that activation of sst2 receptors regulates cGMP levels in the rat retina by increasing NO., suggesting an important role of the sst2 receptor in the regulation of NO/cGMP signaling. In addition, we demonstrate that SRIF release is neuronally released in rat retina. This release is regulated in a negative manner by the activation of the sst1 receptor, suggesting an autoreceptor role for SRIF. These results revealed for the first time the existence of a peptide autoreceptor. The model of chemical ischemia (CI) includes the use of sodium cyanide and iodo-acetic acid, substances that mimic conditions of anoxia and hypoglycemia. Incubation of the retina for one hour in a mixture of CI (NaCN 25mM/IAA 5mM) in conditions of 5% CO2/95% air at 37°C resulted in an attenuation of the number of amacrine cells containing cholineacetyltransfarase, tyrosine hydroxylase and NO. synthase and rodbipolar cells, as determined by immunohistochemical studies. These results were confirmed by TUNEL assays depicting extensive cell death in the CI treated samples. The use of SRIF in the CI did not protect the retina. It was demonstrated with RIA studies that under the conditions of CI SRIF was strongly metabolized. The use of of the sst2 agonists BIM23014 and MK678, and cortistatin provided neuroprotection. The increase in cGMP and NO. levels after sst2 receptor activation in the retina prompted us to study the possible neuroprotective action of NO. in the model of CI. NO. donors, NONOate and SIN-1, as well as 8-Br-cGMP protected the retina from CI. The blockade of NO. synthase and soluble guanylate cyclase reversed the neuroprotective effects of BIM23014. The results of this study suggest new roles for sst2 and sst1 receptors in the retina. They support that the model of CI could be adapted to the retina and will be useful in the study of new neuroprotective targets of retinal disease. The sst2 analogues provide retinal neuroprotection via a mechanism involving the signaling pathway NO. / cGMP.

Degree

thesis:*
Grantor dc:publisher
University of Crete (UOC)
Year dc:date
2011

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Μαστροδήμου, Νίκη
  • Mastrodimou, Niki

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/26737

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Μαστροδήμου, Νίκη; Mastrodimou, Niki. Μελέτη του ρόλου της σωματοστατίνης και κορτιστατίνης στον αμφιβληστροειδή και στην ισχαιμική αμφιβληστροειδοπάθεια. University of Crete (UOC), 2011. http://hdl.handle.net/10442/hedi/26737